跳至主要内容
临床试验/CTRI/2021/05/033851
CTRI/2021/05/033851尚未招募3 期

An Open-Label, Clinical Validation Study to Evaluate the Efficacy and Safety of Unani Pharmacopoeial formulations â?? Qurs Asfar and Roghan Narjeel in Qooba (Dermatophytosis)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group of 18-65 years.
  • 2. Subjects confirmed by direct microscopy
  • 3. Clinical signs and symptoms suggestive of fungal infection

排除标准

  • 1. Subjects on topical treatment within 2 weeks prior to entry into the study
  • 2. Subjects on systemic therapy within 4 weeks prior to entry into the study
  • 3. Subjects with Tineacapitis (tinea of scalp), Onychomycosis (tinea of nails) and Tineabarbae (tinea of beard)
  • 4. Known cases of allergy to any ingredients of the study drug.
  • 5. Subjects with history of diabetes mellitus and systemic illnessrequiring long-term treatment.
  • 6. Lactating and pregnant women

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验

Treatment of Ringworm infection with Unani medicines... | 临床试验